|
|
Office Locations:
|
Four Embarcadero Center, Suite 2100
San Francisco, CA 94111
Phone: 415-875-7777
Fax: 415-364-6944
| | |
|
|
|
- Early
- Expansion
- Growth
- Seed
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
With over $330 million in capital under management, Kearny Venture Partners is a venture capital firm exclusively focused on healthcare products. Kearny Venture Partners focuses on investments in the following areas of healthcare: medical devices and drugs (both small molecules and biopharmaceuticals). The firm is willing to invest in companies at many stages. From founding companies and formation rounds to later stage investments in well-established companies, the firm's typical first investment ranges from $2-8 million. Ultimately, Kearny seeks to invest $10-15 million per company. Kearny Venture Partners is the successor to two prior limited partnerships managed under the titles of ABS Ventures HC and Thomas Weisel Healthcare.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
